Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111848680B reveals a novel bidentate ligand for high-efficiency asymmetric synthesis. Discover cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN111172124B details a YOL151W mutant for high-concentration synthesis, offering cost-effective pharma intermediate manufacturing.
Patent CN114591369B discloses a spirocyclic phosphoramidite ligand enabling high enantioselectivity in palladium-catalyzed reactions, offering robust supply chain solutions.
Novel dual-enzyme mutant catalyst enhances (S)-Bosone production efficiency. Reduces cofactor costs and improves supply chain reliability for cosmetic manufacturers.
Patent CN88101658A reveals a Ni-Ru-M catalyst for high-selectivity reductive amination, offering cost-effective amine production and supply chain stability.
Patent CN112266381B details a cost-effective synthesis of Barosavir intermediates using early resolution, offering significant supply chain advantages for API manufacturers.
Patent CN1764654B details high-yield 4-ODPA synthesis. Reduces costs and improves supply chain reliability for polyetherimide manufacturing.
Patent CN1241906C reveals a Rh-doped Raney nickel catalyst for high-selectivity dinitrile conversion, offering significant cost and supply chain advantages for global manufacturers.
Patent CN115975969B reveals advanced transaminase mutants for Sitagliptin. Achieve high conversion and stereoselectivity for reliable pharmaceutical intermediate supply chains.
Novel Gibberella intermedia method for steroid intermediates. High yield conversion reduces manufacturing costs and ensures supply chain reliability for pharmaceutical partners globally.
Novel patent CN117886699A details a high-yield ambroxol intermediate route. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN119707886A reveals a novel Ru/Zr-W catalyst for efficient amine synthesis. Offers mild conditions, high yield, and supply chain stability for global buyers.
Novel ion-exchange route for D-calcium pantothenate eliminates water generation, boosting yield and purity for reliable vitamin B5 supply chains.
Patent CN102120749A reveals a novel organocatalyst achieving 99% ee in intramolecular Baylis-Hillman reactions, offering a metal-free route for complex API intermediates.
Patent CN102070669B discloses efficient chiral phosphamide ligands enabling high enantioselectivity in cyanosilylation. A reliable partner for cost-effective asymmetric manufacturing.
Patent CN103555683B reveals high-purity saxagliptin intermediate synthesis via PDH mutant. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel thiabendazole synthesis patent CN106349235A offers high yield and reduced environmental impact. Reliable supplier for agrochemical intermediates with cost-effective scaling.
Patent CN119431226A reveals a visible light catalytic method for beta-aryl beta-pyridyl alkyl ketones offering mild conditions and scalable supply chain advantages.
Patent CN101284797A details enzymatic resolution of N-protected allylglycinate using subtilisin crystals for high purity chiral intermediates.
Patent CN119569736B reveals a proline-catalyzed route for Sitagliptin. This method offers high purity and significant cost reduction for pharmaceutical supply chains.